Difference between revisions of "Fujiwara Y, et al. Cancer Sci. (2019) cited as Ref 640 in DOI: 10.1038/s41392-020-0110-5 (Q9903)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Volume (P103): 110, #quickstatements; #temporary_batch_1590009084631)
(‎Created claim: title (P93): Tolerability and efficacy of durvalumab in Japanese patients with advanced solid tumors, #quickstatements; #temporary_batch_1590010982689)
Property / title
 +
Tolerability and efficacy of durvalumab in Japanese patients with advanced solid tumors (English)
Property / title: Tolerability and efficacy of durvalumab in Japanese patients with advanced solid tumors (English) / rank
 +
Normal rank

Revision as of 22:06, 20 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Fujiwara Y, et al. Cancer Sci. (2019) cited as Ref 640 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Fujiwara Y
    0 references
    0 references
    2019
    0 references
    Cancer Sci.
    0 references
    110
    0 references
    Tolerability and efficacy of durvalumab in Japanese patients with advanced solid tumors (English)
    0 references